Trial intelligence / Profile preview

Modeling of LDL lipoproteins in familial hypercholesterolemia vs healthy subjects under atorvastatin

2014-005473-36Phase 4Completed

Sponsor
Universitätsklinikum Freiburg
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of atorvastatin in familial hypercholesterolemia (FH) (2 arms), sponsored by Universitätsklinikum Freiburg. Primary endpoint: Apolipoprotein B, triglyceride, free cholesterol and cholesteryl ester distribution in LDL and subfractions. Started Jan 2015; status: completed.

02

Drugs

atorvastatin
03

Conditions

familial hypercholesterolemia (FH)

Beyond the preview

Go deeper on 2014-005473-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005473-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call